<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<?xml-stylesheet href="drugsmodel.xsl" type="text/xsl" ?>
<model xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="0.6" xsi:noNamespaceSchemaLocation="drug.xsd">

  <!-- Drug history -->

  <history>
    <creator>
      <name>Sylvain Goutelle</name>
      <institution>CHUV</institution>
      <email>sylvain.goutelle@chuv.ch</email>
      <date>2017-08-03</date>
      <comments>
          <comment lang="en">Based on article of Yamamoto et al
          Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease typeJ Clin Pharm Ther 2009 34 473-483 »</comment>
        <comment lang="en">
        Age range : 20-100 years
        Weight range : 29-97 kg
        Disease : Healthy subjects (n=6) and adult patients with infections
        </comment>
        </comments>
    </creator>
    <revisions>
      <revision>
        <name>Yann Thoma</name>
        <institution>HEIG-VD</institution>
        <email>yann.thoma@heig-vd.ch</email>
        <date>2017-08-14</date>
        <comments>
        <comment lang="en">Corrected CL and V1 operations
        </comment>
        </comments>
      </revision>
        <revision>
          <name>Yann Thoma</name>
          <institution>HEIG-VD</institution>
          <email>yann.thoma@heig-vd.ch</email>
          <date>2018-10-30</date>
          <comments>
          <comment lang="en">Added the bibtex reference
          </comment>
          </comments>
        </revision>
    </revisions>
  </history>

  <!-- Drug data -->

  <drug>

    <!-- Drug description -->

    <head>
      <atc>J01XA01</atc>
      <drugid>vancomycin</drugid>
      <drugmodelid>ch.heig-vd.ezechiel.vancomycin.adult</drugmodelid>
      <pkmodelid>ezechiel.model.linear.2comp.infus.clv</pkmodelid>
      <drugnames>
        <name lang="en">Vancomycin</name>
        <name lang="fr">Vancomycine</name>
      </drugnames>
      <domainnames>
        <name lang="en">Adult  patients,
        (Age range: 20-100 years, Weight range: 29-97 kg, Creatinine range: 76-106 ml/min)</name>
        <name lang="fr">Patients adultes </name>
      </domainnames>
      <studynames>
        <name lang="en">Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type</name>
      </studynames>
      <references>
          <reference type='bibtex'>@article{doi:10.1111/j.1365-2710.2008.01016.x,
author = {Yamamoto, M. and Kuzuya, T. and Baba, H. and Yamada, K. and Nabeshima, T.},
title = {Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type},
journal = {Journal of Clinical Pharmacy and Therapeutics},
volume = {34},
number = {4},
pages = {473-483},
keywords = {bacteremia, pneumonia, population pharmacokinetics, vancomycin},
doi = {10.1111/j.1365-2710.2008.01016.x},
url = {https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2710.2008.01016.x},
eprint = {https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2710.2008.01016.x},
abstract = {Summary Objective:  To describe the population pharmacokinetics of vancomycin in patients with gram-positive infections and to investigate the influence of type of infectious disease. Methods:  A two-compartment open model was adopted as a pharmacokinetic model. The nonlinear mixed-effects model was used to analyze the population pharmacokinetic models. Results:  We propose one general model and one infectious disease type-specific model. The general model showed that vancomycin clearance (CL) was linearly correlated with estimated creatinine clearance (CLCR) when CLCR was less than 85 mL/min, as expressed by CL(L/h) = 0·0322 × CLCR + 0·32. The distribution volumes of the central and peripheral compartment were different in healthy volunteers and patients with gram-positive infections. The infectious disease type-specific model showed that these differences were more pronounced in patients with pneumonia. Conclusion:  The population pharmacokinetic parameters of vancomycin obtained here can be used to individualize the dosage of vancomycin in institutions with similar patient population characteristics.}
}
</reference>
      </references>
      <descs>
        <desc lang="en">...</desc>
        <desc lang="fr">...</desc>
      </descs>
      <brands>
        <brand>Vancomycin</brand>
      </brands>
      <comments/>
    </head>

    <!-- Drug adme and intake -->

    <adme>
      <intake>infu</intake>
      <distribution>2</distribution>
      <elimination>linear</elimination>
      <comments/>
    </adme>

    <!-- Drug half-life -->

    <halflife>
      <unit>h</unit>
      <value>6</value>
      <multiplier>10</multiplier>
      <comments/>
    </halflife>

    <!-- Drug units and conversions -->

    <conversions>
      <units>
        <concentration>mg/l</concentration>
        <result>mg/l</result>
      </units>
      <factors>
        <concentration>0</concentration>
        <result>0</result>
      </factors>
      <molarmass>0</molarmass>
      <comments>
			<comment lang="en">No conversion</comment>
			<comment lang="fr">Pas de conversion</comment>
        </comments>
    </conversions>

    <!-- Drug dosages -->

    <dosages>
      <doses default="1000" unit="mg" any="false">
        <dose>250</dose>
        <dose>500</dose>
        <dose>750</dose>
        <dose>1000</dose>
        <dose>1250</dose>
        <dose>1500</dose>
        <dose>1750</dose>
        <dose>2000</dose>
        <dose>2500</dose>
        <dose>3000</dose>
      </doses>
      <intervals default="12" unit="h" any="false">
        <interval>6</interval>
        <interval>8</interval>
        <interval>12</interval>
        <interval>18</interval>
        <interval>24</interval>
        <interval>36</interval>
        <interval>48</interval>
        <interval>72</interval>
        <interval>96</interval>
      </intervals>
      <infusions default="60" unit="min" any="false">
        <infusion>60</infusion>
        <infusion>120</infusion>
        <infusion>240</infusion>
      </infusions>
      <comments>
      </comments>
    </dosages>

    <!-- Drug targets -->

    <targets>
      <target>
        <type>residual</type>
        <concentrations unit="mg/l">
          <min>
            <value>10</value>
            <formula/>
          </min>
          <max>
            <value>20</value>
            <formula/>
          </max>
          <best>
            <value>15</value>
            <formula/>
          </best>
        </concentrations>
        <comments>
          <comment lang="en">As seen with Aline for the residual concentration</comment>
          <comment lang="fr">Vu avec Aline pour la concentration résiduelle</comment>
        </comments>
      </target>
    </targets>

    <!-- Drug covariates -->

    <covariates>
      <covariate>
        <id>CLcr</id>
        <names>
          <name lang="en">Clearance of creatinine</name>
          <name lang="fr">Clairance de la créatinine</name>
        </names>
        <descs>
          <desc lang="en">Clearance of creatinine</desc>
          <desc lang="fr">Clairance de la créatinine</desc>
        </descs>
        <unit>ml/min</unit>
        <type>double</type>
        <defaultvalue>80</defaultvalue>
        <comments>
          <comment lang="en">About the mean value in patients</comment>
        </comments>
      </covariate>
      <covariate>
        <id>bodyweight</id>
        <names>
          <name lang="en">Total Body Weight</name>
          <name lang="fr">Poids total</name>
        </names>
        <descs>
          <desc lang="en">Total body weight of patient, in kilogramms</desc>
          <desc lang="fr">Poids total du patient, en kilogramme</desc>
        </descs>
        <unit>kg</unit>
        <type>double</type>
        <defaultvalue>60</defaultvalue>
        <comments>
          <comment lang="en">About the mean value in patients</comment>
        </comments>
      </covariate>
      <covariate>
        <id>CCRover85</id>
        <names>
          <name lang="en">CCRover85</name>
          <name lang="fr">CCRsup85</name>
        </names>
        <descs>
          <desc lang="en">Creatinine clearance greater than 85 ml/min</desc>
          <desc lang="fr">Clearance de la creatinine supérieure à 85 ml/min</desc>
        </descs>
        <unit/>
        <type>bool</type>
        <defaultvalue>0</defaultvalue>
        <comments><comment lang="en">
        Vanco clearance is correlated with CLcr when ClCr is less than 85 ml/min, fixed when CLCr is more than 85
        </comment></comments>
      </covariate>
    </covariates>

    <!-- Drug error model -->

    <errormodel>
      <additive>0</additive>
      <proportional>0.143</proportional>
      <comments>
      </comments>
    </errormodel>

    <!-- Drug parameters -->

    <parameters>
      <parameter>
        <id>CL</id>
        <unit>l/h</unit>
        <value>2.9</value>
        <bsv>
          <additive>0.0</additive>
          <proportional>0.375</proportional>
        </bsv>
        <min>0</min>
        <max>100</max>
        <step>0.01</step>
        <comments>
          <comment lang="en">Typical clearance calculated for a patients with CCR = 80 ml/min</comment>
        </comments>
      </parameter>
      <parameter>
        <id>V1</id>
        <unit>l</unit>
        <value>28.7</value>
        <bsv>
          <additive>0.0</additive>
          <proportional>0.182</proportional>
        </bsv>
        <min>0</min>
        <max>200</max>
        <step>0.01</step>
        <comments>
          <comment lang="en">Typical volume calculated for an infected patient with weight = 60 kg</comment>
        </comments>
      </parameter>

      <parameter>
        <id>Q</id>
        <unit>l/h</unit>
        <value>8.81</value>
        <bsv>
          <additive>0.0</additive>
          <proportional>0.192</proportional>
        </bsv>
        <min>0</min>
        <max>100</max>
        <step>0.01</step>
        <comments/>
      </parameter>


      <parameter>
        <id>V2</id>
        <unit>l</unit>
        <value>60.6</value>
        <bsv>
          <additive>0.0</additive>
          <proportional>0.728</proportional>
        </bsv>
        <min>0</min>
        <max>400</max>
        <step>0.01</step>
        <comments>
          <comment lang="en">V2 for an infected patient</comment>
        </comments>
      </parameter>

    </parameters>

    <!-- Drug correlations -->

    <correlations>
    </correlations>

    <!-- Drug operations -->

    <operations>
      <operation>
        <parameter>CL</parameter>
        <formula><![CDATA[
CCR = covariate_CLcr;
PATH = covariate_CCRover85;

theta_1 = 0.0322;
theta_2 = 0.32;
theta_3 = 3.83;

if (covariate_CCRover85)
  PATH=1;
else
  PATH=0;

PATH = covariate_CCRover85;

TVCL = (theta_1*CCR+theta_2)*(1-PATH); + theta_3*PATH;
return TVCL;
        ]]></formula>
        <comments/>
      </operation>
      <operation>
        <parameter>V1</parameter>
        <formula><![CDATA[
theta_4 = 0.478;
BW = covariate_bodyweight;

TVV1 = theta_4*BW;
return TVV1;
        ]]></formula>
        <comments/>
      </operation>
    </operations>

    <!-- Drug general comments -->

    <comments>
    </comments>

  </drug>
</model>
